Get Started

Contact us to see if you qualify for one of our medical studies!
Full Name (*)

Please enter your full name.
Phone (*)

Please enter your phone number.
E-mail (*)

Please enter a valid email address.
Location (*)

Please choose a location.
Study (*)

Please choose a study.
How did you hear about us? (*)

Please tell us how you learned about Florida Clinical Research Center.
Comments

Invalid Input
Enter the characters shown below
Enter the characters shown below

Invalid Input




9.jpg

Our News

Making news that changes lives.

Florida Clinical Research Center and our group of outstanding Investigators have dedicated their lives to advancing medical science and changing patients’ lives. With a collective experience of hundreds of clinical trials over several decades, our research and findings are certainly newsworthy.

Beyond our discoveries are those of the medical field overall.
Please click on the CenterWatch news story link below to learn more about the latest happenings in clinical research, study drug trials and the areas of ADHD, Alzheimer’s dementia, Anxiety Disorders, Bipolar Disorder, Chronic Pain, Depression, Diabetes, Fibromyalgia, Hypertension, Insomnia, Migraine Headaches, Obesity, Schizophrenia, Smoking Cessation, Tourette Syndrome and other Men’s and Women’s health medical disorders.

CenterWatch News Stories

 



Florida Clinical Research Center is Sunshine Sponsor for Research Symposium, Coping with Trauma & PTSD PDF Print E-mail
FOR IMMEDIATE RELEASE

Media Contact:
Jamie M. Smith
(941) 747-7900

Bradenton, Florida – January 5, 2012 – Florida Clinical Research Center, LLC (FLCRC), a leading clinical research facility, is a Sunshine sponsor for Sunshine from Darkness’ 15th annual research symposium focusing on “Coping with Trauma and PTSD.”  The symposium is free, open to the public, and will be held on Saturday, January 14, 2012, from 9 a.m. to 1 p.m. at the Van Wezel Performing Arts Hall, 777 N. Tamiami Trail in Sarasota.
Read more... [Florida Clinical Research Center is Sunshine Sponsor for Research Symposium, Coping with Trauma & PTSD]
 
Bipolar disorder type 1 effectively treated with Seroquel PDF Print E-mail

Bipolar type I is serious and can be lethal if left untreated. And because of side effects and differences in personal biology, doctors need as many proven medications as possible in order to combat the disease.

A recent study indicates that Seroquel (quetiapine) is an effective treatment for the manic and mixed symptoms associated with bipolar type I. "Mixed" symptoms involve both depressive and manic elements simultaneously or in quick succession.

Andrew J. Cutler M.D., is CEO and chief medical officer of the Florida Clinical Research Center as well as a courtesy assistant professor of psychiatry at the University of Florida. Dr. Cutler and his team of associates conducted the three-week study.

Read more... [Bipolar disorder type 1 effectively treated with Seroquel]
 
FST Announces NEXT TO NORMAL Talkback, 1/11 PDF Print E-mail

Florida Studio Theatre (FST) will hold a community forum about the Pulitzer Prize-winning musical Next to Normal on Wednesday, January 11, 2012 at 5:00PM in the Keating Theatre (located at 1241 North Palm Avenue, Sarasota FL, 34236). The forum is free to attend, but requires reservations. Reservations can be made by calling the box office at (941) 366-9000.

Moderated by Paul White, LCSW, a psychotherapist based in Sarasota, and Associate Director of FST, Kate Alexander, the forum will feature four panelists of community leaders and actors from the production to discuss the themes presented in the show and the idea of normalcy in our society.

The panelists include:

Dr. Andrew Cutler, a Courtesy Assistant Professor of Psychiatry at the University of Florida and CEO of the Florida Clinical Research Center, LLC.

Read more... [FST Announces NEXT TO NORMAL Talkback, 1/11]
 
New Research From Andrew J. Culter, MD PDF Print E-mail
Visit the Journal of the Academy of Child & Adolescent Psychiatry website to learn more about the Controlled Trial of Extended-Release Guanfacine and Psychostimulants for Attention-Deficit/Hyperactivity Disorder, which was co-authored by and included the participation of FLCRC’s Dr. Andrew J. Cutler.
 
Florida Clinical Research Center helps drug companies find solutions PDF Print E-mail

BRADENTON HERALD

LIVING - HEALTH
Published: Tuesday, Nov. 08, 2011
By Susan Hemmingway - Herald Health Correspondent


Whether you have ADHD, can’t sleep, wheeze with asthma, eat way too much in one sitting, are a smoking teenager, or have sunk into depression, the Florida Clinical Research Center may need you to step up and volunteer for a drug study. All of these conditions have been the past or ongoing focus of the privately owned research center, located in a sunny suite of offices on Cooper Creek Boulevard.

Florida Clinical Research Center tests medications for pharmaceutical companies, with some of its clinical trials including children as young as six. Many times, it is studying how existing drugs can be used in different ways; for instance, whether a medication works to treat a condition beyond what was initially approved for, or how a larger drug dosage compares to a smaller dosage.

Read Article

 
<< Start < Prev 1 2 3 4 5 6 7 Next > End >>

Page 1 of 7